FDA issues biomarker draft guidance; Working group calls for biomarkers in Alzheimer's disease;

> The FDA has released its "Use of Histology in Biomarker Qualification Studies" draft guidance document, which aims to support product development and reduce occurrences of unqualified biomarkers. Guidance document

> A working group calls for the use of biomarkers as surrogate endpoints in Alzheimer's disease clinical trials to improve outcomes for patients. Article

> RainDance Technologies, Hôpital Saint-Louis and BGI are working together in an international collaboration to find and confirm genetic variants in rheumatoid arthritis. Press release

> Researchers from Perth, Australia, find a microRNA biomarker in prostate cancer patient samples. Article

> Inherited gene mutations can increase the risk of developing pancreatic cancer. Article

> Exosomes in spinal fluid could be a source for biomarkers in neurological disease. Abstract

> Protein biomarkers can differ between primary and recurrent ovarian cancers. Abstract

> A Cancer Research UK imaging biomarker shows potential to predict lack of response to chemotherapy. Abstract

> ValiRx acquires the biomarkers arm of the Finnish company Pharmatest. Article

> The copeptin malaria biomarker does not predict the severity of disease. Abstract

And Finally... Researchers have retracted a 2007 cancer biomarker paper from Urology after a company sued two universities for scientific fraud. Article

Suggested Articles

Takeda tapped Roche’s Foundation Medicine to develop tissue- and blood-based companion diagnostic tests for its portfolio of lung cancer therapies.

Cellex has announced plans to develop a rapid coronavirus test that people can fully perform at home, from sample collection to result, using an app.

More than 20 states either don’t release or have incomplete data on the rapid antigen tests now considered key to containing the coronavirus.